Skip to main content
All lobbying filings

BALLARD SPAHR LLP

BALLARD SPAHR LLP filed a Q1 report for CENCORA, INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) on April 20, 2026, reporting $50,000 in lobbying income.

Lobbying for CENCORA, INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · ​Pharmaceutical sourcing and distribution services company

All filings by BALLARD SPAHR LLP · Everything CENCORA, INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Pennsylvania

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Medicare/Medicaid

Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Extend payment increase under Medicare's physician fee schedule. Reimbursement policies impacting drug shortages Preventing and Mitigating Generic Drug Shortages

Pharmacy

Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA)

 Bills named in this filing 2
  • H.R. 3164
    Ensuring Community Access to Pharmacist Services Act
  • S. 2426
    Equitable Community Access to Pharmacist Services Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem